🕵️ Unicycive Therapeutics, Inc. ($UNCY)
SEC insider & ownership activity, last 12 months · CIK 1766140 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| VIVO Opportunity Fund Holdings, L.P. | 10.0% | 13G | Nov 14, 2025 | filing ↗ | |
| VIVO Opportunity, LLC | 10.0% | 13G | Nov 14, 2025 | filing ↗ | |
| Nantahala Capital Management, LLC | 10.0% | 13G | Feb 13, 2026 | filing ↗ | |
| Wilmot B. Harkey | 10.0% | 13G | Feb 13, 2026 | filing ↗ | |
| Daniel Mack | 10.0% | 13G | Feb 13, 2026 | filing ↗ | |
| BVF Partners L P/IL | 10.0% | 13G | Aug 14, 2025 | filing ↗ | |
| BVF INC/IL | 10.0% | 13G | Aug 14, 2025 | filing ↗ | |
| Mark N. Lampert | 10.0% | 13G | Aug 14, 2025 | filing ↗ | |
| RA Capital Management, L.P. | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Peter Kolchinsky | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Rajeev Shah | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| BVF GP Holdings LLC | 9.7% | 13G | Aug 14, 2025 | filing ↗ | |
| Biotechnology Value Fund L P | 5.7% | 13G | Aug 14, 2025 | filing ↗ | |
| BVF I GP LLC | 5.7% | 13G | Aug 14, 2025 | filing ↗ | |
| Millennium Management LLC | exited | 13G | Jul 8, 2026 | filing ↗ | |
| Millennium Group Management LLC | exited | 13G | Jul 8, 2026 | filing ↗ | |
| Israel A. Englander | exited | 13G | Jul 8, 2026 | filing ↗ | |
| Integrated CORE Strategies (US) LLC | exited | 13G | Jul 8, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| VIVO Opportunity Fund Holdings, L.P. | $9.5M | Jun 30, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 2, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 19, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 5, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 6, 2026 | filing ↗ |
| Earnings (2.02) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Other events (8.01) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Earnings (2.02) | Oct 28, 2025 | filing ↗ |
| Other events (8.01) | Oct 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 28, 2025 | filing ↗ |
| Other events (8.01) | Aug 15, 2025 | filing ↗ |
| Other events (8.01) | Aug 15, 2025 | filing ↗ |
| Earnings (2.02) | Aug 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2025 | filing ↗ |